David A Katz

Scientist, entrepreneur, artist.

[David A Katz @davidkatz47]

@EricTopol @matthewherper @jburnmurdoch @FT Look at the data on a per capita basis. Tells a different story. US has just passed China.

[David A Katz @davidkatz47]

@VisualCap Have you considered a plot of these data on a per capita basis? That would provide an interesting and complementary view of the epidemic.

[David A Katz @davidkatz47]

@OregonGovBrown Here's something to fix in a special legislative session - Oregonians deserve high-performance public health emergency preparedness!
https://t.co/p1KYHuDK8s

[David A Katz @davidkatz47]

#prednisone is among the best of drugs & the worst of drugs. Millions rely on it to control autoimmune diseases, but with many side effects. What if patients could get the benefits without many of the side effects? That's the goal at @sparrowpharma

https://t.co/2M1VO6TAwp

[David A Katz @davidkatz47]

Greed doesn’t pay. Company decisions like these have given our industry a bad rep that we shouldn’t have.

[Biotechnology Innovation Organization @IAmBiotech]

"Doctors filling out forms essentially had only one choice: request the expensive option." Must-read piece in @BW on the broken prescription drug pricing market and why lower list prices often do NOT benefit benefits. https://t.co/i8V3jn8QVg

[David A Katz @davidkatz47]

US must reduce healthcare costs including drug costs. But reference pricing drugs to foreign prices isn't a valid approach. The GOP alternative proposal is toothless and even worse. Sad that there's not a good proposal in Congress. @repblumenauer @repgregwalden @RepSchrader

[David A Katz @davidkatz47]

Nice to see a next-generation steroid for eosinophilic esophagitis highlighted as the 1st growth product expected from Takeda's Shire purchase. It'll be even better to have next-generation steroids for all the patients who rely on prednisone for long-term disease management.

[John Carroll @JohnCendpts]

What does $62B buy you these days? A lot, says Takeda execs as the pharma player promises a blockbuster R&D future
https://t.co/hfNryPug9x

[David A Katz @davidkatz47]

This is a nice recognition for the potential impact of our efforts to deliver next generation steroid products with a substantially improved safety profile compared to today’s steroids such as prednisone.
https://t.co/FDz0Y2q2NI

[David A Katz @davidkatz47]

This was yesterday! #oregonbio2019 @OregonBio @sparrowpharma #portlandispersonable #PortlandOR #Entrepreneurship

[David A Katz @davidkatz47]

And we won. More on that later. @OregonBio @sparrowpharma #PortlandOR #Entrepreneurship

[Oregon Life Sciences @OregonBio]

Seems @sparrowpharma has done a great job de-risking drug development. Bioscience #investors are taking note. “Sparrow is a drab little animal that most overlook. But it can FLY”. Great pitch today at #oregonbio2019 by President, David Katz.

[David A Katz @davidkatz47]

Listen to me talk about next-generation steroids at the @PopHeatlhShow. Come listen and enjoy! https://t.co/6ewki2qr7U #pophealthshow #gohealthhero #podcast #drugspharmaceuticals #innovation #autoimmunediseases #portlandoregon #startups

[David A Katz @davidkatz47]

#daimlerphotobomb #rctid #craterlake ⁦@NatlParkService⁩ ⁦@TimbersFC⁩

[David A Katz @davidkatz47]

Are you ready for some football? #daimlerphotobomb

[David A Katz @davidkatz47]

Lewis never mentioned #pdxcarpet #RevolutionaryWarAirports

[David A Katz @davidkatz47]

I am not throwing away my mini bottle of whiskey. A. Hamilton #RevolutionaryWarAirports

[David A Katz @davidkatz47]

@sparrowpharma wins best seed stage company at Cascadia Venture Forum! #investors #Vancouver

[Keiretsu Forum NW @k4northwest]

Great presentation @sparrowpharma! #AngelCapitalExpo
#investors #investorcapital #networking

[David A Katz @davidkatz47]

Lots of investors in the room to learn about ⁦@sparrowpharma⁩ ! ⁦@k4northwest⁩ #angelcapitalexpo

[David A Katz @davidkatz47]

"Sparrow has promising technology to create a medical breakthrough for many patients. As a co-investor with David on several deals, we are impressed with his diligent efforts to select winners." -Weiland Street Capital
Come see us Friday! @sparrowpharma @k4northwest

[David A Katz @davidkatz47]

"Prevail considers Sparrow an attractive investment based on the clinical and commercial potential for its novel therapeutic programs, ..." Learn the rest of their investment thesis on Friday! @sparrowpharma @k4northwest